317 related articles for article (PubMed ID: 29132330)
21. Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population.
Yilmaz M; Tas A; Donmez G; Kacan T; Silig Y
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1059-1062. PubMed ID: 29699057
[TBL] [Abstract][Full Text] [Related]
22. The 72Pro Variant of the Tumor Protein 53 Is Associated with an Increased Breast Cancer Risk in the Moroccan Population.
Ayoubi SE; Elkarroumi M; El Khachibi M; Hassani Idrissi H; Ayoubi H; Ennachit S; Arazzakou M; Nadifi S
Pathobiology; 2018; 85(4):247-253. PubMed ID: 29949804
[TBL] [Abstract][Full Text] [Related]
23. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
24. The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis.
Cai X; Yang M
J Cancer Res Clin Oncol; 2012 Apr; 138(4):555-61. PubMed ID: 22205265
[TBL] [Abstract][Full Text] [Related]
25. Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.
Yang M; Guo Y; Zhang X; Miao X; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
Carcinogenesis; 2007 Sep; 28(9):1996-2001. PubMed ID: 17638920
[TBL] [Abstract][Full Text] [Related]
26. Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.
Yoneda T; Kuboyama A; Kato K; Ohgami T; Okamoto K; Saito T; Wake N
Oncol Rep; 2013 Jul; 30(1):25-34. PubMed ID: 23624782
[TBL] [Abstract][Full Text] [Related]
27. The Relationship between Gene Polymorphisms od the XRCC1 and TP53 with the Gender of Children with Acute Leukemia.
Usenova A; Akhunbaev S; Tumanbaev A; Lim E
Asian Pac J Cancer Prev; 2023 Feb; 24(2):613-621. PubMed ID: 36853312
[TBL] [Abstract][Full Text] [Related]
28. Association of DNA repair genes XRCC1 (Arg399Gln), (Arg194Trp) and XRCC3 (Thr241Met) polymorphisms with the risk of breast cancer: a case-control study in Egypt.
Ramadan RA; Desouky LM; Elnaggar MA; Moaaz M; Elsherif AM
Genet Test Mol Biomarkers; 2014 Nov; 18(11):754-60. PubMed ID: 25340946
[TBL] [Abstract][Full Text] [Related]
29. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
30. [Association of
Yang F; Xiong P; Yuan XL; Liu CR; Ran LJ; Yang Y; Li JY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Mar; 35(3):189-192. PubMed ID: 28511303
[No Abstract] [Full Text] [Related]
31. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
[TBL] [Abstract][Full Text] [Related]
32. Association of XRCC1 Arg399GIn and Tp53 Arg72Pro polymorphisms and increased risk of uterine leiomyoma - A case-control study.
Yaghmaei M; Salimi S; Namazi L; Farajian-Mashhadi F
Genet Mol Biol; 2015 Dec; 38(4):444-9. PubMed ID: 26692154
[TBL] [Abstract][Full Text] [Related]
33. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.
Ebid GT; Sedhom IA; El-Gammal MM; Moneer MM
Asian Pac J Cancer Prev; 2012; 13(9):4315-20. PubMed ID: 23167335
[TBL] [Abstract][Full Text] [Related]
34. MDM2 and TP53 Polymorphisms as Predictive Markers for Head and Neck Cancer in Northeast Indian Population: Effect of Gene-Gene and Gene-Environment Interactions.
Bhowmik A; Das S; Bhattacharjee A; Choudhury B; Naiding M; Deka S; Ghosh SK; Choudhury Y
Asian Pac J Cancer Prev; 2015; 16(14):5767-72. PubMed ID: 26320449
[TBL] [Abstract][Full Text] [Related]
35. Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.
Borchiellini D; Etienne-Grimaldi MC; Bensadoun RJ; Benezery K; Dassonville O; Poissonnet G; Llorca L; Ebran N; Formento P; Château Y; Thariat J; Milano G
Oral Oncol; 2017 Apr; 67():70-76. PubMed ID: 28351583
[TBL] [Abstract][Full Text] [Related]
36. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
Liu GC; Zhou YF; Su XC; Zhang J
BMC Cancer; 2019 Jan; 19(1):24. PubMed ID: 30616520
[TBL] [Abstract][Full Text] [Related]
37. MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia.
Floris M; Sanna D; Castiglia P; Putzu C; Sanna V; Pazzola A; De Miglio MR; Sanges F; Pira G; Azara A; Lampis E; Serra A; Carru C; Steri M; Costanza F; Bisail M; Muroni MR
BMC Cancer; 2020 Mar; 20(1):234. PubMed ID: 32192442
[TBL] [Abstract][Full Text] [Related]
38. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
[TBL] [Abstract][Full Text] [Related]
39. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
40. p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.
Liu G; Cescon DW; Zhai R; Zhou W; Kulke MH; Ma C; Xu W; Su L; Asomaning K; Heist RS; Wain JC; Lynch TJ; Christiani DC
Dis Esophagus; 2010 Jan; 23(1):36-9. PubMed ID: 19302219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
